Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. In 2012, the American ...
Twenty-four patients with human papillomavirus (HPV)-associated cervical intraepithelial neoplasia (CIN); of whom 13 had CIN 1, 8 had CIN 2, and 3 had CIN 3; were treated with recombinant alpha 2b ...
The Dynamic Spectral Imaging System (DYSIS) colposcope with DYSISmap and the ZedScan I adjunctive colposcopy technologies are intended to be used with colposcopy to help identify cervical ...
Level 2: Mid-level evidence A multinational cohort study evaluated 24,295 women who had cervical cytology and HPV screening at baseline and one or more cervical cytology or histopathology exams within ...
OSLO, Norway--(BUSINESS WIRE)--Vaccibody AS announced today vaccination of the first patient in its multicentre trial VB C-01 – an exploratory, open-label, multicenter phase I/IIa study VB10.16 ...
Cervical cancer is diagnosed in more than 3,000 women in the United Kingdom each year, making it the 14 th most common cancer among women as of 2018. During this period, cervical cancer accounted for ...
Actively monitoring abnormal cells (lesions) that line the cervix rather than removing them straight away is associated with an increased long term risk of cervical cancer, suggests a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback